> top > docs > PMC:3586680 > spans > 4264-4567 > annotations

PMC:3586680 / 4264-4567 JSONTXT

Annnotations TAB JSON ListView MergeView

test3

Id Subject Object Predicate Lexical cue
T861 129-132 Protein denotes p53
T827 129-132 Protein denotes p53

testone

Id Subject Object Predicate Lexical cue
T791 129-132 Protein denotes p53

bionlp-st-ge-2016-test-tees

Id Subject Object Predicate Lexical cue
T2297 223-236 Protein denotes α5β1 integrin
T2296 129-132 Protein denotes p53
T2295 94-107 Protein denotes α5β1 integrin

bionlp-st-ge-2016-spacy-parsed

Id Subject Object Predicate Lexical cue
T3157 302-303 . denotes .
T3156 296-302 NNS denotes tumors
T3155 290-295 NN denotes brain
T3154 279-289 JJ denotes high-grade
T3153 275-278 IN denotes for
T3152 268-274 NN denotes target
T3151 256-267 JJ denotes therapeutic
T3150 254-255 DT denotes a
T3149 251-253 IN denotes as
T3148 240-250 VBN denotes considered
T3147 237-239 VBZ denotes is
T3146 228-236 NN denotes integrin
T3145 223-227 JJ denotes α5β1
T3144 221-222 . denotes .
T3143 220-221 -RRB- denotes )
T3142 216-220 CD denotes 2012
T3141 214-215 , denotes ,
T3140 211-214 FW denotes al.
T3139 208-210 FW denotes et
T3138 197-207 NNP denotes Janouskova
T3137 196-197 -LRB- denotes (
T3136 192-195 NNP denotes TMZ
T3135 189-191 TO denotes to
T3134 178-188 NN denotes resistance
T3133 173-177 NN denotes cell
T3132 166-172 NN denotes glioma
T3131 158-165 VBZ denotes induces
T3130 152-157 NN denotes event
T3129 148-151 DT denotes the
T3128 144-147 CC denotes and
T3127 142-143 , denotes ,
T3126 133-142 VBG denotes signaling
T3125 129-132 NN denotes p53
T3124 119-128 VBZ denotes regulates
T3123 108-118 RB denotes negatively
T3122 99-107 NN denotes integrin
T3121 94-98 JJ denotes α5β1
T3120 92-93 . denotes .
T3119 80-92 JJ denotes chemotherapy
T3118 76-79 CC denotes and
T3117 63-75 JJ denotes radiotherapy
T3111 25-28 DT denotes the
T3110 22-24 IN denotes in
T3109 17-21 NN denotes role
T3108 15-16 DT denotes a
T3107 10-14 VBP denotes play
T3106 0-9 NNS denotes Integrins
T3116 60-62 TO denotes to
T3115 52-59 NNS denotes cancers
T3114 43-51 JJ denotes advanced
T3113 40-42 IN denotes of
T3112 29-39 NN denotes resistance
R2148 T3152 T3149 pobj target,as
R2149 T3153 T3152 prep for,target
R2151 T3154 T3156 amod high-grade,tumors
R2152 T3155 T3156 compound brain,tumors
R2154 T3156 T3153 pobj tumors,for
R2155 T3157 T3148 punct .,considered
R2261 T3106 T3107 nsubj Integrins,play
R2265 T3107 T3107 ROOT play,play
R2269 T3108 T3109 det a,role
R2272 T3109 T3107 dobj role,play
R2277 T3110 T3109 prep in,role
R2279 T3111 T3112 det the,resistance
R2281 T3112 T3110 pobj resistance,in
R2282 T3113 T3112 prep of,resistance
R2284 T3114 T3115 amod advanced,cancers
R2285 T3115 T3113 pobj cancers,of
R2288 T3116 T3117 aux to,radiotherapy
R2292 T3117 T3115 relcl radiotherapy,cancers
R2295 T3118 T3117 cc and,radiotherapy
R2296 T3119 T3117 conj chemotherapy,radiotherapy
R2298 T3120 T3107 punct .,play
R2302 T3121 T3122 amod α5β1,integrin
R2306 T3122 T3124 nsubj integrin,regulates
R2313 T3123 T3124 advmod negatively,regulates
R2317 T3124 T3124 ROOT regulates,regulates
R2322 T3125 T3124 dobj p53,regulates
R2325 T3126 T3125 acl signaling,p53
R2329 T3127 T3124 punct ",",regulates
R2333 T3128 T3124 cc and,regulates
R2337 T3129 T3130 det the,event
R2339 T3130 T3131 nsubj event,induces
R2341 T3131 T3124 conj induces,regulates
R2342 T3132 T3134 amod glioma,resistance
R2346 T3133 T3134 compound cell,resistance
R2349 T3134 T3131 dobj resistance,induces
R2353 T3135 T3134 prep to,resistance
R2358 T3136 T3135 pobj TMZ,to
R2365 T3137 T3140 punct (,al.
R2369 T3138 T3140 nmod Janouskova,al.
R2373 T3139 T3140 nmod et,al.
R2376 T3140 T3134 appos al.,resistance
R2377 T3141 T3140 punct ",",al.
R2379 T3142 T3140 npadvmod 2012,al.
R2384 T3143 T3131 punct ),induces
R2388 T3144 T3124 punct .,regulates
R2392 T3145 T3146 amod α5β1,integrin
R2396 T3146 T3148 nsubjpass integrin,considered
R2400 T3147 T3148 auxpass is,considered
R2405 T3148 T3148 ROOT considered,considered
R2408 T3149 T3148 prep as,considered
R2414 T3150 T3152 det a,target
R2418 T3151 T3152 amod therapeutic,target

bionlp-st-ge-2016-test-ihmc

Id Subject Object Predicate Lexical cue
T2499 129-142 Positive_regulation denotes p53 signaling
T2486 0-9 Entity denotes Integrins
T2390 166-177 Entity denotes glioma cell
T2386 129-132 Protein denotes p53
T2372 192-221 Entity denotes TMZ (Janouskova et al., 2012)
R1562 T2386 T2499 causeOf p53,p53 signaling

DLUT931

Id Subject Object Predicate Lexical cue
T2195 119-128 Regulation denotes regulates
T2175 129-132 Protein denotes p53
R1498 T2175 T2195 themeOf p53,regulates

BioNLP16_Messiy

Id Subject Object Predicate Lexical cue
T2251 129-132 Protein denotes p53

BioNLP16_DUT

Id Subject Object Predicate Lexical cue
T2117 129-132 Protein denotes p53

bionlp-st-ge-2016-uniprot

Id Subject Object Predicate Lexical cue
T2157 129-132 http://www.uniprot.org/uniprot/P04637 denotes p53

bionlp-st-ge-2016-test-proteins

Id Subject Object Predicate Lexical cue
T1958 129-132 Protein denotes p53

pmc-enju-pas

Id Subject Object Predicate Lexical cue
T1538 284-290 NN denotes grade
T1537 279-284 NN denotes high-
T1536 268-278 JJ denotes target for
T1535 265-268 IN denotes ic
T1534 259-265 NN denotes rapeut
T1533 248-259 JJ denotes ed as a the
T1532 247-248 DT denotes r
T1531 245-247 IN denotes de
T1530 235-245 VB denotes n is consi
T1529 233-235 VB denotes ri
T1528 225-233 NN denotes β1 integ
T1527 221-225 CD denotes . α5
T1526 220-221 -RRB- denotes )
T1525 216-220 CD denotes 2012
T1524 214-215 -COMMA- denotes ,
T1523 211-214 FW denotes al.
T1522 208-210 FW denotes et
T1521 197-207 NNP denotes Janouskova
T1520 196-197 -LRB- denotes (
T1519 192-195 NN denotes TMZ
T1518 189-191 TO denotes to
T1517 178-188 NN denotes resistance
T1516 173-177 NN denotes cell
T1515 166-172 NN denotes glioma
T1514 158-165 VB denotes induces
T1513 152-157 NN denotes event
T1512 148-151 DT denotes the
T1511 144-147 CC denotes and
T1510 142-143 -COMMA- denotes ,
T1509 133-142 NN denotes signaling
T1508 129-132 NN denotes p53
T1507 119-128 VB denotes regulates
T1506 108-118 RB denotes negatively
T1505 99-107 NN denotes integrin
T1504 94-98 NN denotes α5β1
T1503 80-93 NN denotes chemotherapy.
T1502 76-79 CC denotes and
T1501 63-75 NN denotes radiotherapy
T1500 60-62 TO denotes to
T1499 52-59 NN denotes cancers
T1498 43-51 JJ denotes advanced
T1497 40-42 IN denotes of
T1496 29-39 NN denotes resistance
T1495 25-28 DT denotes the
T1494 22-24 IN denotes in
T1493 17-21 NN denotes role
T1492 15-16 DT denotes a
T1491 10-14 VB denotes play
T1490 0-9 NN denotes Integrins
R1039 T1490 T1491 arg1Of Integrins,play
R1040 T1491 T1494 arg1Of play,in
R1041 T1491 T1502 arg1Of play,and
R1042 T1493 T1491 arg2Of role,play
R1043 T1493 T1492 arg1Of role,a
R1044 T1496 T1494 arg2Of resistance,in
R1045 T1496 T1495 arg1Of resistance,the
R1046 T1496 T1497 arg1Of resistance,of
R1047 T1496 T1500 arg1Of resistance,to
R1048 T1499 T1497 arg2Of cancers,of
R1049 T1499 T1498 arg1Of cancers,advanced
R1050 T1501 T1500 arg2Of radiotherapy,to
R1051 T1502 T1511 arg1Of and,and
R1052 T1505 T1503 arg1Of integrin,chemotherapy.
R1053 T1505 T1504 arg1Of integrin,α5β1
R1054 T1505 T1507 arg1Of integrin,regulates
R1055 T1507 T1502 arg2Of regulates,and
R1056 T1507 T1506 arg1Of regulates,negatively
R1057 T1509 T1507 arg2Of signaling,regulates
R1058 T1509 T1508 arg1Of signaling,p53
R1059 T1511 T1510 arg1Of and,","
R1060 T1513 T1512 arg1Of event,the
R1061 T1513 T1514 arg1Of event,induces
R1062 T1514 T1511 arg2Of induces,and
R1063 T1517 T1514 arg2Of resistance,induces
R1064 T1517 T1515 arg1Of resistance,glioma
R1065 T1517 T1516 arg1Of resistance,cell
R1066 T1517 T1518 arg1Of resistance,to
R1067 T1519 T1518 arg2Of TMZ,to
R1068 T1519 T1520 arg1Of TMZ,(
R1069 T1519 T1529 modOf TMZ,ri
R1070 T1521 T1520 arg2Of Janouskova,(
R1071 T1521 T1522 arg1Of Janouskova,et
R1072 T1521 T1523 arg1Of Janouskova,al.
R1073 T1521 T1524 arg1Of Janouskova,","
R1074 T1525 T1524 arg2Of 2012,","
R1075 T1526 T1520 arg3Of ),(
R1076 T1528 T1527 arg1Of β1 integ,. α5
R1077 T1528 T1529 arg1Of β1 integ,ri
R1078 T1528 T1530 arg2Of β1 integ,n is consi
R1079 T1530 T1529 arg2Of n is consi,ri
R1080 T1530 T1531 arg1Of n is consi,de
R1081 T1534 T1531 arg2Of rapeut,de
R1082 T1534 T1532 arg1Of rapeut,r
R1083 T1534 T1533 arg1Of rapeut,ed as a the
R1084 T1534 T1535 arg1Of rapeut,ic
R1085 T1538 T1535 arg2Of grade ,ic
R1086 T1538 T1536 arg1Of grade ,target for
R1087 T1538 T1537 arg1Of grade ,high-

2_test

Id Subject Object Predicate Lexical cue
23459853-22593187-38778510 216-220 22593187 denotes 2012

UBERON-AE

Id Subject Object Predicate Lexical cue
T874 290-295 http://purl.obolibrary.org/obo/UBERON_0000955 denotes brain

GO-BP

Id Subject Object Predicate Lexical cue
T2005 133-142 http://purl.obolibrary.org/obo/GO_0023052 denotes signaling

sentences

Id Subject Object Predicate Lexical cue
T895 0-303 Sentence denotes Integrins play a role in the resistance of advanced cancers to radiotherapy and chemotherapy. α5β1 integrin negatively regulates p53 signaling, and the event induces glioma cell resistance to TMZ (Janouskova et al., 2012). α5β1 integrin is considered as a therapeutic target for high-grade brain tumors.
T31 0-303 Sentence denotes Integrins play a role in the resistance of advanced cancers to radiotherapy and chemotherapy. α5β1 integrin negatively regulates p53 signaling, and the event induces glioma cell resistance to TMZ (Janouskova et al., 2012). α5β1 integrin is considered as a therapeutic target for high-grade brain tumors.

simple1

Id Subject Object Predicate Lexical cue
T2065 129-132 Protein denotes p53